Q3 FY2026 · ended Sep 30, 2026 · Revenue $416.24M, +8.4% YoY · Filed Oct 29, 2026
Merit Medical Systems Inc (MMSI) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In Q3 of fiscal 2026, the quarter ended Sep 30, 2026, it reported revenue of $416.2 million and net income of $42.3 million. Free cash flow was $52.9 million. As of Sep 30, 2026 it held $503.6 million in cash and investments and $822.1 million in total debt.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- MMSI (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- UT
- Headquarters
- South Jordan, UT
- SEC filer status
- Large accelerated filer
- SEC CIK
- 856982
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2026 Sep 30, 2026 |
Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $416.2M | $418.8M | $381.9M | $393.9M | $384.2M |
| Operating income | $58.8M | $60.4M | $44.2M | $54.2M | $42.6M |
| Net income | $42.3M | $38.8M | $41.0M | $38.0M | $27.8M |
| Diluted EPS | $0.70 | $0.65 | $0.68 | $0.63 | $0.46 |
| Operating cash flow | $65.3M | $69.3M | $40.7M | $98.5M | $75.0M |
| Free cash flow | $52.9M | $51.9M | $24.7M | $74.0M | $52.5M |
| Total assets | $2.9B | $2.9B | $2.7B | $2.7B | $2.6B |
| Total liabilities | $1.2B | $1.2B | $1.1B | $1.1B | $1.1B |
| Stockholders' equity | $1.7B | $1.7B | $1.6B | $1.6B | $1.5B |
| Cash and investments | $503.6M | $448.7M | $488.1M | $446.4M | $392.5M |
| Total debt | $822.1M | $820.1M | $821.6M | $821.6M | $821.2M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Oct 29, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Oct 29, 2026 | Oct 29, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Aug 20, 2026 | Aug 14, 2026 |
| 10-Q | Quarterly report | Jul 30, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jul 30, 2026 | Jul 30, 2026 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results, Regulation FD disclosure
|
May 19, 2026 | May 13, 2026 |
All 1001 Merit Medical Systems Inc SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.